This Is MS Multiple Sclerosis Community: Knowledge & Support

The Clinical Neuroscience Laboratory at Ohio State University is looking for individuals with multiple sclerosis to participate in an online study examining relations between emotion regulation and quality of life in individuals with MS. The online study involves filling out a set of questionnaires. The entire survey will take between 60 and 90 minutes and you will be emailed a $10 amazon gift certificate for your participation.

You may qualify for this study if you ...

Bioness L300 Plus for Foot Drop PLUS Thigh Weakness. Almost New unit was used for just 3 months up until surgery July, 2014. Purchase price of $13,000. In 'as new' condition. Comes complete with all parts, users guide, carrying case. Unit is able to be individualized with calibration by trained therapist with prescription.

The Bioness L300 Plus System consists of four main components that communicate wirelessly to provide synchronized ankle dorsiflexion and knee flexion or ...

http://www.mshope.com

Matt is Ashton Embry's (founder of Direct-MS) son. Matt was diagnosed with MS 20 years ago. He's not selling anything....just offering some hope and healing.
Kudos to Matt for going public with his MS diagnosis and sharing this important information.
He's a film maker...so these videos are really well done.

http://www.mshope.com


cheer

I personally think this new technology is more for SCI patients that have a specific location of the injury.

Science may soon lead the paralyzed to walking again as a new cyborg-like technology is making waves in spinal cord injury research. Researchers at Ecole Polytechnique Fédérale de Lausanne (The Swiss Federal Institute of Technology in Lausanne) have developed a tiny, ribbon-like prosthetic which has restored movement in paralyzed rats.

The implant, dubbed “e-Dura,” for the ...

just scored a big ass chunk of funding. it's been a long time coming. yessss!!

Arena Pharmaceuticals, Inc. released the first results from its phase 1b trial that for the evaluation of an oral drug candidate called APD334 for the treatment of autoimmune diseases, such as multiple sclerosis (MS). The multiple ascending dose clinical trial demonstrated encouraging findings about the drug, which is designed to target the sphingosine 1-phosphate subtype 1 (S1P1) receptor............ Read More - http://www.ms-uk.org/emergingtherapies

Hi,

Got a bad dose of the flu at the moment and was just about to take some night nurse medication when my wife told me the chemist advised again it.

I've checked the night nurse leaflet and there is no mention of avoiding if you have ms.
Have also googled without any results indicating that i shouldn't?

Has anyone else out there ever heard about any reasons why i can't take the medication?

I ...

Okay so I will introduce myself here. My name is Becca and I am 23 years old. I grew up with a mother with MS my whole life, and she raised me to be who I am today. Long story short my issues began at age 18 when I woke up one morning and couldn't see out of my right eye. The ER flushed it and I could still not see. Went to the eye ...

Common sense is not very common nowadays. Specially in the MS research world. At least there are some authors that use it still.

They conclude that "if the initiating cause is poorly understood then curing MS is unlikely".

And this sentence is remarkably important because most research groups are trying to cure EAE or to understand the immunology of the demyelination. And these events are not related at all with the MS starting events nor ...